Cees de Wolff
Directeur/Membre du Conseil chez PamGene BV
Profil
Cees de Wolff is currently serving as Director-Supervisory Board at PamGene BV, Director at Dutch Life Sciences Coöperatie UA, and Founding Investor at Lupus Ventures BV.
Previously, he worked as Director at Immunovo BV and Member-Supervisory Board at Pepscan Therapeutics BV.
He completed his undergraduate degree at the University of Groningen.
Postes actifs de Cees de Wolff
| Sociétés | Poste | Début |
|---|---|---|
PamGene BV
 PamGene BV Pharmaceuticals: MajorHealth Technology PamGene BV provides biopharmaceutical products and clinical settings. It also provides PamChip biomarkers, such as tyrosine kinases, serine/threonine kinases, nuclear receptors, and reagent kits. The firm provides BioNavigator, a software tool for interpretation of PamChip measurements, as well as for performing data analysis for various PamChip experiments; and Evolve that enables data capture and analysis, as well as for the export of data into third party software formats. The company was founded by Tim Kievits in December 1999 and is headquartered in 's-Hertogenbosch, the Netherlands. | Directeur/Membre du Conseil | 27/05/2010 |
Lupus Ventures BV
 Lupus Ventures BV Investment ManagersFinance Lupus Ventures BV provides financial services. Its headquarters are located in Heerenveen, Netherlands. | Corporate Officer/Principal | 11/07/2011 |
Dutch Life Sciences Coöperatie UA
 Dutch Life Sciences Coöperatie UA Miscellaneous Commercial ServicesCommercial Services Dutch Life Sciences Coöperatie UA is a company based in 's-Hertogenbosch, Netherlands. The company provides services to Dutch family offices by onboarding skills in the field of business, intellectual property, finance, and marketing and communication. The company collaborates with specialists to accelerate life sciences and make a difference. The company uses cookies to enhance the user experience on their website and also uses content and scripts from third parties. Eveline Hogenkamp-van Velp has been the CEO of the company since 2019. | Directeur/Membre du Conseil | - |
Anciens postes connus de Cees de Wolff
| Sociétés | Poste | Fin |
|---|---|---|
Pepscan Therapeutics BV
 Pepscan Therapeutics BV Pharmaceuticals: MajorHealth Technology Pepscan Therapeutics BV develops immunotherapeutic products in oncology. The company was founded in 2000 and is headquartered in Lelystad, the Netherlands. | Directeur/Membre du Conseil | - |
Immunovo BV
 Immunovo BV BiotechnologyHealth Technology Immunovo BV develops immune therapeutics in the field of oncology. The firm's research focuses on therapeutic vaccines based on synthetic peptide antigens for which the company applies the novel and proprietary techniques in synthetic immunogen development. Its products include Sclerostin, PD1, PEPA10-adj, Gastrine, VEGF, and GnRH. The company was founded in 2009 and is headquartered in ‘s-Hertogenbosch, the Netherlands. | Directeur/Membre du Conseil | - |
Formation de Cees de Wolff
| University of Groningen | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
PamGene BV
PamGene BV Pharmaceuticals: MajorHealth Technology PamGene BV provides biopharmaceutical products and clinical settings. It also provides PamChip biomarkers, such as tyrosine kinases, serine/threonine kinases, nuclear receptors, and reagent kits. The firm provides BioNavigator, a software tool for interpretation of PamChip measurements, as well as for performing data analysis for various PamChip experiments; and Evolve that enables data capture and analysis, as well as for the export of data into third party software formats. The company was founded by Tim Kievits in December 1999 and is headquartered in 's-Hertogenbosch, the Netherlands. | Health Technology |
Lupus Ventures BV
Lupus Ventures BV Investment ManagersFinance Lupus Ventures BV provides financial services. Its headquarters are located in Heerenveen, Netherlands. | Finance |
Pepscan Therapeutics BV
Pepscan Therapeutics BV Pharmaceuticals: MajorHealth Technology Pepscan Therapeutics BV develops immunotherapeutic products in oncology. The company was founded in 2000 and is headquartered in Lelystad, the Netherlands. | Health Technology |
Immunovo BV
Immunovo BV BiotechnologyHealth Technology Immunovo BV develops immune therapeutics in the field of oncology. The firm's research focuses on therapeutic vaccines based on synthetic peptide antigens for which the company applies the novel and proprietary techniques in synthetic immunogen development. Its products include Sclerostin, PD1, PEPA10-adj, Gastrine, VEGF, and GnRH. The company was founded in 2009 and is headquartered in ‘s-Hertogenbosch, the Netherlands. | Health Technology |
Dutch Life Sciences Coöperatie UA
Dutch Life Sciences Coöperatie UA Miscellaneous Commercial ServicesCommercial Services Dutch Life Sciences Coöperatie UA is a company based in 's-Hertogenbosch, Netherlands. The company provides services to Dutch family offices by onboarding skills in the field of business, intellectual property, finance, and marketing and communication. The company collaborates with specialists to accelerate life sciences and make a difference. The company uses cookies to enhance the user experience on their website and also uses content and scripts from third parties. Eveline Hogenkamp-van Velp has been the CEO of the company since 2019. | Commercial Services |